Cellular immunotherapy in multiple myeloma: Lessons from preclinical models

被引：20

作者：

Binsfeld, M. ^{[1
]}

Fostier, K. ^{[2
]}

Muller, J. ^{[1
]}

Baron, F. ^{[1
,3
,4
]}

Schots, R. ^{[2
]}

Beguin, Y. ^{[1
,3
,4
]}

Heusschen, R. ^{[1
]}

Caers, J. ^{[1
,3
,4
]}

机构：

[1] Univ Liege, GIGA Res, Hematol Lab, B-4000 Liege, Belgium

[2] Univ Ziekenhuis Brussel UZ Brussel, Dept Clin Hematol, Brussels, Belgium

[3] Univ Liege, Div Hematol, Dept Med, B-4000 Liege, Belgium

[4] CHU Liege, Liege, Belgium

来源：

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2014年 / 1846卷 / 02期

关键词：

Multiple myeloma; Mouse models; Immunotherapy; Transplantation; Adoptive transfer; Vaccination; REGULATORY T-CELLS; NATURAL-KILLER-CELLS; COMPLEX CLASS-II; PROTECTIVE IMMUNE-RESPONSES; MARROW STROMAL CELLS; DENDRITIC CELLS; BONE-MARROW; SUPPRESSOR-CELLS; ANTITUMOR IMMUNITY; PERIPHERAL-BLOOD;

D O I：

10.1016/j.bbcan.2014.08.001

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The majority of multiple myeloma patients relapse with the current treatment strategies, raising the need for alternative therapeutic approaches. Cellular immunotherapy is a rapidly evolving field and currently being translated into clinical trials with encouraging results in several cancer types, including multiple myeloma. Murine multiple myeloma models are of critical importance for the development and refinement of cellular immunotherapy. In this review, we summarize the immune cell changes that occur in multiple myeloma patients and we discuss the cell-based immunotherapies that have been tested in multiple myeloma, with a focus on murine models. (C) 2014 Elsevier B.V. All rights reserved.

引用

页码：392 / 404

页数：13

共 50 条

[21] Evolution of cellular immunotherapy: from allogeneic transplant to dendritic cell vaccination as treatment for multiple myeloma
Arnason, Jon
Avigan, David
[J]. IMMUNOTHERAPY, 2012, 4 (10) : 1043 - 1051
[22] Immunotherapy of multiple myeloma
Ruffini, PA
Kwak, LW
[J]. SEMINARS IN HEMATOLOGY, 2001, 38 (03) : 260 - 267
[23] Immunotherapy in multiple myeloma
Hutchins, Irene M.
Schachter, Levanto G.
Mahindra, Anuj K.
[J]. TRANSLATIONAL CANCER RESEARCH, 2017, 6 (01) : 109 - 116
[24] IMMUNOTHERAPY IN MULTIPLE MYELOMA
Gleason, Charise
Catamero, Donna D.
[J]. SEMINARS IN ONCOLOGY NURSING, 2017, 33 (03) : 292 - 298
[25] Immunotherapy in Multiple Myeloma
Soekojo, Cinnie Yentia
Ooi, Melissa
de Mel, Sanjay
Chng, Wee Joo
[J]. CELLS, 2020, 9 (03)
[26] Immunotherapy in Multiple Myeloma
Knop, S.
[J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 245 - 245
[27] Immunotherapy of multiple myeloma
Minnie, Simone A.
Hill, Geoffrey R.
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (04): : 1565 - 1575
[28] Immunotherapy for Multiple Myeloma
Tamura, Hideto
Ishibashi, Mariko
Sunakawa, Mika
Inokuchi, Koiti
[J]. CANCERS, 2019, 11 (12)
[29] Immunotherapy for multiple myeloma
Rosenblatt, Jacalyn
Bar-Natan, Michal
Munshi, Nikhil C.
Avigan, David E.
[J]. EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (01) : 91 - 96
[30] Immunotherapy for Multiple Myeloma
Kroeger, Nicolaus
Mohty, Mohamad
Nagler, Arnon
Yi, Qing
[J]. CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2012,

← 1 2 3 4 5 →